Identifying and Treating the Metabolic Syndrome
A 45-year-old male presents to an obesity medicine specialist for evaluation. His body mass index (BMI) is 40 kg/m2. His past medical history is significant for hypertension (HTN) and dyslipidemia. Medications include hydrochlorothiazide, losartan, rosuvastatin, and a daily aspirin. Blood pressure has been difficult to control despite his medications, and his cardiologist is considering adding a third agent. Family history is notable for both parents with obesity and HTN; his father had bariatric surgery. One of his sisters is overweight and has type 2 diabetes. He works as the manager of a construction company and is on his feet most of the day. He denies any use of tobacco and drinks one to two beers every night. His typical diet consists of a breakfast of eggs and toast, and then he will typically eat out for lunch and dinner, often stopping for dinner at fast-food restaurants on his way home.
KeywordsMetabolic syndrome Obesity Body mass index Insulin resistance LDL-C Diet
- 1.Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52. https://doi.org/10.1161/circulationaha.105.169404.CrossRefPubMedPubMedCentralGoogle Scholar
- 3.National Institute for Health and Clinical Excellence (NICE) guidelines. BMI: preventing ill health and premature death in black, Asian and other minority ethnic groups. July 2013. https://www.nice.org.uk/advice/lgb13.
- 4.National Institutes of Health/National Heart, Lung, and Blood Institute. Managing overweight and obesity in adults: systematic evidence review from the obesity expert panel. Nov 2013. https://www.nhlbi.nih.gov/health-topics/managing-overweight-obesity-in-adults.
- 5.International Diabetes Foundation. The IDF consensus worldwide definition of the metabolic syndrome. 2016.Google Scholar
- 6.Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud’homme D, Nadeau A, Despres JP. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179.CrossRefGoogle Scholar
- 7.Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, Shofer JB, Fish BE, Knopp RH, Kahn SE. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087–94.CrossRefGoogle Scholar